Association of melatonin &MTNR1B variants with type 2 diabetes in Gujarat population.
- Resource Type
- Article
- Authors
- Patel, Roma; Rathwa, Nirali; Palit, Sayantani Pramanik; Ramachandran, A.V.; Begum, Rasheedunnisa
- Source
- Biomedicine & Pharmacotherapy. Jul2018, Vol. 103, p429-434. 6p.
- Subject
- *MELATONIN
*PHYSIOLOGICAL effects of melatonin
*GENETICS of type 2 diabetes
*TYPE 2 diabetes treatment
*SINGLE nucleotide polymorphisms
*BLOOD sugar measurement
*THERAPEUTICS
- Language
- ISSN
- 0753-3322
Aim/hypothesis Melatonin is a circadian rhythm regulator and any imbalance in its levels can be related to various metabolic disorders. Melatonin and the genetic variants of Melatonin Receptor 1B ( MTNR1B ) are reported to be associated with Type 2 Diabetes (T2D) susceptibility. The aim of the present study was to investigate i) plasma melatonin levels ii) Single Nucleotide Polymorphisms (SNPs) of MTNR1B and iii) Genotype-phenotype correlation analysis in T2D patients. Methods Plasma and PBMCs were separated from venous blood of 478 diabetes patients and 502 controls. Genomic DNA was isolated from PBMCs. PCR-RFLP was used for genotyping. Melatonin was estimated from plasma samples by ELISA. Results Our study suggests: i) decreased plasma melatonin levels in T2D patients and, ii) association of MTNR1B rs10830963 GG genotype with increased Fasting Blood Glucose (FBG). Conclusion It can be concluded that reduced titer of melatonin along with altered FBG due to MTNR1B genetic variant could act as a potent risk factor towards T2D in Gujarat population. [ABSTRACT FROM AUTHOR]